Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats

PLoS One. 2017 Feb 13;12(2):e0171372. doi: 10.1371/journal.pone.0171372. eCollection 2017.

Abstract

Type 1 diabetes is associated with abberations of fat metabolism before and after the clinical onset of disease. It has been hypothesized that the absence of the effect of insulin in the liver contributes to reduced hepatic fat synthesis. We measured hepatic gene expression and serum metabolites before and after the onset of hyperglycemia in a BioBreeding rat model of type 1 diabetes. Functional pathway annotation identified that lipid metabolism was differentially expressed in hyperglycemic rats and that these pathways significantly overlapped with genes regulated by insulin. 17 serum metabolites significantly changed in concentration. All but 2 of the identified metabolites had previously been reported in type 1 diabetes, and carbohydrates were overall the most upregulated class of metabolites. We conclude that lack of insulin in the liver contributes to the changes in fat metabolism observed in type 1 diabetes. Further studies are needed to understand the clinical consequences of a lack of insulin in the liver in patients with type 1 diabetes.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Breeding
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / metabolism
  • Female
  • Gas Chromatography-Mass Spectrometry
  • Gene Expression Profiling / methods
  • Hyperglycemia / blood
  • Hyperglycemia / genetics*
  • Hyperglycemia / metabolism
  • Insulin / metabolism
  • Lipid Metabolism / genetics*
  • Liver / metabolism
  • Male
  • Metabolome*
  • Metabolomics / methods
  • Rats, Inbred BB
  • Rats, Inbred F344
  • Signal Transduction / genetics
  • Time Factors
  • Transcriptome / genetics*

Substances

  • Blood Glucose
  • Insulin

Grants and funding

ÅL has received support for this study from the Swedish Research Council (K2011-54X-15312-07-6), the Juvenile Diabetes Research Foundation, The Swedish Diabetes Foundation, SUS Funds, and the Skåne County Council for Research and Development. MJH was supported by National Institutes of Health grant R01AI078713 and The Children's Hospital of Wisconsin Foundation. TM has received support from the Knut and Alice Wallenberg Foundation, the UPSC Berzelii project, and Biobanking and Molecular Resource Infrastructure of Sweden. SER and ÅL received a grant from the Swedish Child Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.